Generic placeholder image

Current Pharmaceutical Analysis

Editor-in-Chief

ISSN (Print): 1573-4129
ISSN (Online): 1875-676X

Research Article

Simultaneous Determination of Six Components in Jingzhiguanxin Tablet by High-Performance Liquid Chromatography

Author(s): Hui Jiang, Lianhao Fu, Yu Wang, Shaozhi Wang, Xiaoxu Zhang, Xijie Zhang and Xiaohong Liu*

Volume 15, Issue 2, 2019

Page: [130 - 137] Pages: 8

DOI: 10.2174/1573412914666180315120130

Price: $65

Abstract

Background: Jingzhiguanxin (JZGX) tablet, a traditional Chinese prescription, is commonly used for treating coronary heart disease and angina pectoris in the clinic. There are six active components (Danshensu (DSS), Protocatechuic aldehyde (PD), Paeoniflorin (PF), Ferulic acid (FA), Salvianolic acid B (Sal B) and Tanshinone IIA (TA)) in JZGX tablet.

Objective: In this paper, a simple and reliable method was used for simultaneous determining the six active components by high-performance liquid chromatography coupled with diode array detector (HPLC-DAD).

Methods: These six active components were separated on an Agilent Zorbax Eclipse XDB-C18 column (150 mmx4.6 mm, 5 µm) at 30 °C. Acetonitrile (A), methanol (B) and 0.5% H3PO4 aqueous solution (C) were used as mobile phase for gradient elution. The flow rate was 1 mL/min and the detection wavelengths were set at 280 nm for DSS, PD and Sal B, 230 nm for PF, 320 nm for FA and 270 nm for TA, respectively.

Results: All of the six components showed good linearity regressions (r2≥0.9997) in the detected concentration range. The recovery rates and coefficient of variation (CV) for all analytes were 98.66%- 100.18% and 0.75%-1.89%, respectively. This method was successfully applied to simultaneously determine the six components in JZGX tablet from different batches and manufacturers.

Conclusion: The validated method can be used in routine quality control analysis of JZGX tablet without any interference.

Keywords: High-Performance Liquid Chromatography (HPLC), Diode Array Detection (DAD), Jingzhiguanxin (JZGX) tablet, active components, components determination, quality control.

Graphical Abstract
[1]
Liu, J.; Mu, J.; Zheng, C.; Chen, X.; Guo, Z.; Huang, C.; Fu, Y.; Tian, G.; Shang, H.; Wang, Y. Systems-pharmacology dissection of traditional chinese medicine compound saffron formula reveals multi-scale treatment strategy for cardiovascular diseases. Sci. Rep., 2016, 6, 19809.
[2]
Cole, J.A.; Smith, S.M.; Hart, N.; Cupples, M.E. Systematic review of the effect of diet and exercise lifestyle interventions in the secondary prevention of coronary heart disease. Cardiol. Res. Pract., 2010, 2011, 232351.
[3]
Kones, R. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des. Devel. Ther., 2011, 5, 325-380.
[4]
Mozaffarian, D.; Benjamin, E.J.; Go, A.S.; Arnett, D.K.; Blaha, M.J.; Cushman, M.; de Ferranti, S.; Despres, J.P.; Fullerton, H.J.; Howard, V.J.; Huffman, M.D.; Judd, S.E.; Kissela, B.M.; Lackland, D.T.; Lichtman, J.H.; Lisabeth, L.D.; Liu, S.; Mackey, R.H.; Matchar, D.B.; McGuire, D.K.; Mohler, E.R., 3rd; Moy, C.S.; Muntner, P.; Mussolino, M.E.; Nasir, K.; Neumar, R.W.; Nichol, G.; Palaniappan, L.; Pandey, D.K.; Reeves, M.J.; Rodriguez, C.J.; Sorlie, P.D.; Stein, J.; Towfighi, A.; Turan, T.N.; Virani, S.S.; Willey, J.Z.; Woo, D.; Yeh, R.W.; Turner, M.B. American Heart Association Statistics, C.; Stroke Statistics, S. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation, 2015, 131(4), e29-e322.
[5]
Kanu, J.S.; Gu, Y.; Zhi, S.; Yu, M.; Lu, Y.; Cong, Y.; Liu, Y.; Li, Y.; Yu, Y.; Cheng, Y.; Liu, Y. Single nucleotide polymorphism rs3774261 in the AdipoQ gene is associated with the risk of coronary heart disease (CHD) in Northeast Han Chinese population: a case-control study. Lipids Health Dis., 2016, 15, 6.
[6]
Liu, B.; Du, Y.; Cong, L.; Jia, X.; Yang, G. Danshen (Salvia miltiorrhiza) compounds improve the biochemical indices of the patients with coronary heart disease. Evid. Based Complement. Alternat. Med., 2016, 2016, 9781715.
[7]
Zhu, W.; Chen, L.; Zhu, J.; Chen, X.; Li, J. Comparative studies on protective effects of Guanxindanshen Recipe, Jingzhiguanxin Recipe and Shuxiong Recipe in acute myocardial ischemia rats. Journal of Jiangxi College of Traditional Chinese Medicine (In Chinese)., 2013, 25(5), 3.
[8]
Zhu, W.; Zhu, J.; Li, J.; Chen, X.; Chen, L. Effects of Guanxin Danshen Prescription, refined Guanxin prescription and Shu Fang Recipe on hemodynamics in rats with acute myocardial ischemia. J. Jiangxi College Trad. Chin. Med., 2013, 11, 3.
[9]
Shao, F.; Wang, Q.; Chen, L.; Liu, R.; Ren, G.; Huang, H.; Chen, H. Effects of different polarity part in Jingzhiguanxin Tablet on neutrophil respiratory burst and antioxidation. J. Chin. Medic. Mat., 2012, 35(11), 3.
[10]
Wang, X.; Yan, K.; Ma, X.; Li, W.; Chu, Y.; Guo, J.; Li, S.; Zhou, S.; Zhu, Y.; Liu, C. Simultaneous determination and pharmacokinetic study of protocatechuic aldehyde and its major active metabolite protocatechuic acid in rat plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. Sci., 2016, 54(5), 697-705.
[11]
Gao, S.; Liu, Z.; Li, H.; Little, P.J.; Liu, P.; Xu, S. Cardiovascular actions and therapeutic potential of tanshinone IIA. Atherosclerosis, 2012, 220(1), 3-10.
[12]
Guo, M.; Liu, Y.; Shi, D. Cardiovascular actions and therapeutic potential of tetramethylpyrazine (active component isolated from rhizoma chuanxiong): Roles and mechanisms. BioMed Res. Int., 2016, 2016, 2430329.
[13]
Zhang, L.L.; Tian, K.; Tang, Z.H.; Chen, X.J.; Bian, Z.X.; Wang, Y.T.; Lu, J.J. Phytochemistry and pharmacology of carthamus tinctorius L. Am. J. Chin. Med., 2016, 44(2), 197-226.
[14]
Jin, S.N.; Wen, J.F.; Wang, T.T.; Kang, D.G.; Lee, H.S.; Cho, K.W. Vasodilatory effects of ethanol extract of Radix Paeoniae Rubra and its mechanism of action in the rat aorta. J. Ethnopharmacol., 2012, 142(1), 188-193.
[15]
Yang, Z.H.; Mei, C.; He, X.H.; Sun, X.B. Advance in studies on chemical constitutions, pharmacological mechanism and pharmacokinetic profile of dalbergiae odoriferae lignum. Zhongguo Zhongyao Zazhi, 2013, 38(11), 1679-1683.
[16]
Yasuda, T.; Takasawa, A.; Nakazawa, T.; Ueda, J.; Ohsawa, K. Inhibitory effects of urinary metabolites on platelet aggregation after orally administering Shimotsu-To, a traditional Chinese medicine, to rats. J. Pharm. Pharmacol., 2003, 55(2), 239-244.
[17]
Li, J.M.; Zhao, Y.H.; Zhong, G.C.; Long, Z.J.; Zhou, P.; Yuan, M. Synthesis of ferulic acid derivatives and their inhibitory effect on platelet aggregation. Yao Xue Xue Bao, 2011, 46(3), 305-310.
[18]
Chen, Y.; Wang, W.; Yang, H. Content determination of paeoniflorin and tanshinone IIA in fine coronary tablet by HPLC. Appl. Chem. Ind., 2012, 41(3), 3.
[19]
Zhenou, J.B.L.; Hongcong, Q.; Mao, Li. Content determination of Salvianolic Acid B in Jingzhi Guanxin Tablet by HPLC. Guid. J. Chinese Med. Pharm., 2011, 17(1), 3.
[20]
Pang, H.; Wu, L.; Tang, Y.; Zhou, G.; Qu, C.; Duan, J.A. Chemical analysis of the herbal medicine salviae miltiorrhizae Radix et Rhizoma (Danshen). Molecules, 2016, 21(1), 51.
[21]
Hu, Y.; Lu, T.; Mao, C.; Wu, H.; Zhang, X.; Wang, J.; Gu, J. Simultaneous determination of 10 components in traditional Chinese medicine Dachaihu Granule by reversed-phase-high-performance liquid chromatographic-diode array detector. Pharmacogn. Mag., 2013, 9(33), 33-38.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy